Find a Doctor

Rong-nan N. Chien

Chang Gung Memorial Hospital

Bio


Rong-nan Chien is in Taoyuan, Taiwan. They have been an author on 112 peer reviewed articles and participated in 2 clinical trials in the past 15 years.

Contact

Taoyuan, TNQ, TW

Latest Advances


Latest Advance
Study
  • Condition: Patients with Type 2 Diabetes (T2D) with Non-Alcoholic Fatty Liver Diseases (NAFLDs)
  • Journal: BMJ open diabetes research & care
  • Treatment Used: Sodium Glucose Co-transporter 2 (SGLT2) Inhibitors
  • Number of Patients: 0
  • Published —
This review of the literature examined the effects of sodium glucose co-transporter 2 (SGLT2) inhibitors in patients with type 2 diabetes (T2D) with non-alcoholic fatty liver diseases (NAFLDs).
Latest Advance
Study
  • Condition: Type 2 Diabetes
  • Journal: Cardiovascular diabetology
  • Treatment Used: Sodium Glucose Cotransporter 2 Inhibitors (SGLT2)
  • Number of Patients: 10140
  • Published —
This study compared the glycemic (blood sugar) and pleiotropic effects in patients with type 2 diabetes initiating sodium glucose cotransporter 2 (SGLT2) inhibitors or dipeptidyl peptidase-4 (DPP4) inhibitors.
Latest Advance
Study
  • Condition: Hepatitis C Virus (HCV) Genotype 1
  • Journal: Journal of viral hepatitis
  • Treatment Used: Elbasvir/Grazoprevir
  • Number of Patients: 700
  • Published —
This study evaluated he effectiveness and liver/renal safety of elbasvir/grazoprevir in patients with hepatitis C virus (HCV) genotype 1.
Latest Advance
Study
  • Condition: Severe Hepatitis Flare in HBeAg-Negative Chronic Hepatitis B (HBV)
  • Journal: Journal of viral hepatitis
  • Treatment Used: Re-Treatment
  • Number of Patients: 22
  • Published —
This study tested whether off-therapy hepatitis B virus (HBV) flares require immediate re-treatment or if re-treatment can be held or is not necessary
Latest Advance
Study
  • Condition: Advanced Hepatocellular Carcinoma (aHCC)
  • Journal: The pharmacogenomics journal
  • Treatment Used: GALNT14 rs9679162 Genotype-Guided Therapeutic Strategy: Systemic or Hepatic Arterial Infusion Chemotherapy (HAIC)
  • Number of Patients: 237
  • Published —
This study investigated a combination of three previously identified single nucleotide polymorphism (SNP) predictors (GALNT14-rs9679162, WWOX-rs13338697, and rs6025211) could guide the choice between systemic chemotherapy, hepatic arterial infusion chemotherapy (HAIC), and targeted agents in patients with advanced hepatocellular carcinoma (aHCC).
Latest Advance
Study
  • Condition: Aminotransferase (ALT) levels in people with type 2 diabetes
  • Journal: Diabetes, obesity & metabolism
  • Treatment Used: Sodium-glucose co-transporter-2 inhibitors
  • Number of Patients: 1300000
  • Published —
The study researched the effects of sodium-glucose co-transporter-2 inhibitors on aminotransferase (ALT) levels in people with type 2 diabetes.
Latest Advance
Study
  • Condition: Treatment-Naive Chronic Hepatitis C Genotype 1B with Mild Fibrosis
  • Journal: The Journal of infectious diseases
  • Treatment Used: Elbasvir/Grazoprevir
  • Number of Patients: 82
  • Published —
This study tested the safety and efficacy of using elbasvir/grazoprevir to treat patients with treatment-naive chronic hepatitis C genotype 1B with mild fibrosis.
Latest Advance
Study
  • Condition: Hepatitis C virus genotype 1b (HCV-1b)
  • Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
  • Treatment Used: Daclatasvir, asunaprevir plus ribavirin
  • Number of Patients: 68
  • Published —
This phase III study investigated whether including ribavirin to the daclatasvir plus asunaprevir (DVC + ASV) combination could shorten the original 12-week treatment regimen.
Latest Advance
Study
  • Condition: chronic hepatitis B patients with low surface antigen levels
  • Journal: Hepatology international
  • Treatment Used: multiple doses of hepatitis B recombinant vaccine
  • Number of Patients: 19
  • Published —
The purpose of the study was to determine the effectiveness of the administration of multiple doses of hepatitis B recombinant vaccine in chronic hepatitis B patients with low surface antigen levels.

Clinical Trials


This doctor has not participated in any recent clinical trials.

All Publications
View All


Publication
Study
  • Journal: Virulence
  • Published —
Altering retinol binding protein 4 levels in hepatitis C: Inflammation and steatosis matter.
Publication
Study
  • Journal: BMJ open diabetes research & care
  • Published —
SGLT2 inhibitors in patients with type 2 diabetes with non-alcoholic fatty liver diseases: an umbrella review of systematic reviews.

Contact

Taoyuan, TNQ, TW

Insurance

Contact them to find out if they accept your insurance plan.